[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

UY25040A1 - Derivados de 9-desoxo-9a-aza-9a-homoeritromicina a c-4' sustituidos - Google Patents

Derivados de 9-desoxo-9a-aza-9a-homoeritromicina a c-4' sustituidos

Info

Publication number
UY25040A1
UY25040A1 UY25040A UY25040A UY25040A1 UY 25040 A1 UY25040 A1 UY 25040A1 UY 25040 A UY25040 A UY 25040A UY 25040 A UY25040 A UY 25040A UY 25040 A1 UY25040 A1 UY 25040A1
Authority
UY
Uruguay
Prior art keywords
infections
formula
compounds
hydroxy
derivatives
Prior art date
Application number
UY25040A
Other languages
English (en)
Spanish (es)
Inventor
Edward Alan Glazer
Bingwei Vera Yang
Michael Anthony Letavic
Brian Scott Bronk
Takushi Kaneko
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21959336&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY25040(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of UY25040A1 publication Critical patent/UY25040A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
UY25040A 1997-06-11 1998-06-11 Derivados de 9-desoxo-9a-aza-9a-homoeritromicina a c-4' sustituidos UY25040A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4934897P 1997-06-11 1997-06-11

Publications (1)

Publication Number Publication Date
UY25040A1 true UY25040A1 (es) 2000-09-29

Family

ID=21959336

Family Applications (1)

Application Number Title Priority Date Filing Date
UY25040A UY25040A1 (es) 1997-06-11 1998-06-11 Derivados de 9-desoxo-9a-aza-9a-homoeritromicina a c-4' sustituidos

Country Status (50)

Country Link
US (4) US6420536B1 (sr)
EP (1) EP0988310B9 (sr)
JP (2) JP3315704B2 (sr)
KR (1) KR100396168B1 (sr)
CN (4) CN1793155B (sr)
AP (1) AP1231A (sr)
AR (1) AR013086A1 (sr)
AT (1) ATE251173T1 (sr)
AU (1) AU749816B2 (sr)
BG (1) BG64391B1 (sr)
BR (1) BRPI9810519B8 (sr)
CA (1) CA2293823C (sr)
CO (1) CO4950611A1 (sr)
CZ (1) CZ298556B6 (sr)
DE (2) DE69818665T2 (sr)
DK (1) DK0988310T3 (sr)
DZ (1) DZ2514A1 (sr)
EA (1) EA002441B1 (sr)
EG (1) EG24081A (sr)
ES (1) ES2205487T3 (sr)
FR (1) FR04C0013I2 (sr)
GT (1) GT199800077A (sr)
HK (3) HK1028048A1 (sr)
HN (1) HN1998000086A (sr)
HR (1) HRP980314B1 (sr)
HU (2) HU228005B1 (sr)
ID (1) ID22992A (sr)
IL (1) IL132809A0 (sr)
IS (1) IS1998B (sr)
LU (1) LU91076I9 (sr)
MA (1) MA24564A1 (sr)
ME (1) ME00876B (sr)
MY (1) MY123354A (sr)
NL (1) NL300150I2 (sr)
NO (1) NO316911B1 (sr)
NZ (2) NZ514871A (sr)
OA (1) OA11224A (sr)
PA (1) PA8452201A1 (sr)
PE (1) PE79699A1 (sr)
PL (1) PL191601B1 (sr)
PT (1) PT988310E (sr)
RS (1) RS49675B (sr)
SI (1) SI0988310T1 (sr)
SK (1) SK284171B6 (sr)
TN (1) TNSN98082A1 (sr)
TW (1) TW472060B (sr)
UA (1) UA67744C2 (sr)
UY (1) UY25040A1 (sr)
WO (1) WO1998056802A1 (sr)
ZA (1) ZA985017B (sr)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
EP1779853A3 (en) * 1997-09-10 2010-01-27 Merial Ltd. 9a-azalides as veterinary antimicrobial agents
ATE353014T1 (de) * 1997-09-10 2007-02-15 Merial Ltd Verwendung von 9a-azaliden als antimikrobielle mittel für tiere
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
EP1437360A3 (en) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11 Carbamates of macrolide antibacterials
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
CA2292359C (en) * 1999-01-28 2004-09-28 Pfizer Products Inc. Novel azalides and methods of making same
JP3897983B2 (ja) * 1999-05-18 2007-03-28 ファイザー・プロダクツ・インク マクロライド系抗生物質の新規結晶
OA11945A (en) * 1999-05-24 2006-04-13 Pfizer Prod Inc 13-Methyl erythromycin derivatives.
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
US6764996B1 (en) 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
JP2003507487A (ja) * 1999-08-24 2003-02-25 アボット・ラボラトリーズ 抗菌活性を有する９ａ−アザライド類
US6608033B1 (en) 1999-08-27 2003-08-19 Pfizer Inc. Treatment or prevention of coccidiosis
DK1250343T3 (da) * 2000-01-27 2003-09-22 Pfizer Prod Inc Sammensætninger med et azalid antibiotikum
HUP0300585A3 (en) * 2000-04-27 2003-09-29 Pfizer Prod Inc Process for the use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals
RU2263117C2 (ru) * 2001-04-27 2005-10-27 Пфайзер Продактс Инк. Способ получения 4"-замещенных производных 9-деоксо-9а-аза-9а-гомоэритромицина а
AU2002317415A1 (en) * 2001-08-01 2003-02-17 Pfizer Products Inc. Azalide antibiotic compositions
US7601695B2 (en) 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
US7276487B2 (en) 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
CA2546195A1 (en) * 2003-11-21 2005-06-02 Pfizer Products Inc. The use of anti biotics as vaccine adjuvants
RS52365B (sr) * 2004-03-16 2012-12-31 Boehringer Ingelheim International Gmbh Derivati benzola supstituisani glukopiranozilom, lekovi koji sadrže ova jedinjenja, njihova primena i postupak za njihovo dobijanje
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7402568B2 (en) 2004-09-29 2008-07-22 Enanta Pharmaceuticals, Inc. Bicyclic 9a-azalide derivatives
US7767797B1 (en) * 2004-09-30 2010-08-03 Synovo Gmbh Macrocyclic compounds and methods of use thereof
US7271155B2 (en) 2005-01-07 2007-09-18 Enanta Pharmaceuticals, Inc. 9A, 11-2C-bicyclic 9a-azalide derivatives
JP2008526948A (ja) * 2005-01-14 2008-07-24 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 抗マラリア活性を有する９ａ−カルバモイルおよびチオカルバモイルアザライド
WO2009055557A1 (en) 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
EP3031460A1 (en) 2008-10-24 2016-06-15 Cempra Pharmaceuticals Inc. Biodefenses using triazole-containing macrolides
US9937194B1 (en) * 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
EP2475253B1 (en) 2009-09-10 2016-10-26 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and mac diseases
DK2550286T3 (en) 2010-03-22 2016-02-29 Cempra Pharmaceuticals Inc CRYSTALLINE FORMS OF A MACROLID AND APPLICATIONS THEREOF
US9051346B2 (en) 2010-05-20 2015-06-09 Cempra Pharmaceuticals, Inc. Process for preparing triazole-containing ketolide antibiotics
KR20180110181A (ko) 2010-09-10 2018-10-08 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
WO2012038372A1 (en) 2010-09-20 2012-03-29 Novartis Ag Novel process for the preparation of 9-deoxo-9a-aza- 9a-homoerythromycin a modified in the c-4'' of the cladinose ring by an epoxide group
US9145436B2 (en) * 2010-10-10 2015-09-29 Michael W. Burnet Anti-inflammatory macrolides
CN102993250B (zh) * 2011-07-06 2016-02-10 洛阳惠中兽药有限公司 C-3取代的-9-脱氧-9a-氮杂-9a-高红霉素a衍生物
CN102260306B (zh) * 2011-07-22 2012-07-18 山东鲁抗舍里乐药业有限公司 一种制备泰拉霉素的方法
EP2736915A1 (en) 2011-07-27 2014-06-04 Farma GRS, d.o.o. New crystalline forms of tulathromycin
MX2014011537A (es) 2012-03-27 2015-02-10 Cempra Pharmaceuticals Inc Formulaciones parenterales para la administracion de antibioticos macrolidos.
CN102786569B (zh) * 2012-09-07 2016-12-07 安徽中升药业有限公司 泰拉霉素中间体及其制备方法与泰拉霉素的制备方法
RU2015138796A (ru) 2013-03-14 2017-04-19 Семпра Фармасьютикалс, Инк. Способы и составы для лечения респираторных заболеваний
EP2968384A4 (en) 2013-03-15 2017-02-15 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
WO2015014907A1 (en) * 2013-07-31 2015-02-05 Farma Grs, D.O.O. Process for preparation of tulathromycin
CN103497227B (zh) * 2013-09-13 2015-09-30 青岛科技大学 一种泰拉菌素中间体的制备方法
CN104725446B (zh) * 2015-03-26 2017-10-27 宁夏泰瑞制药股份有限公司 一种从泰拉霉素粗品中分离泰拉霉素a和泰拉霉素b的方法
CN104861018A (zh) * 2015-06-17 2015-08-26 瑞普（天津）生物药业有限公司 一种泰拉菌素的制备方法
CN105646617A (zh) * 2016-01-21 2016-06-08 杭州海尔希畜牧科技有限公司 一种制备泰拉霉素的方法
FR3048612B1 (fr) * 2016-03-14 2020-10-02 Septeos Tulathromycine potentialisee
CN106046077B (zh) * 2016-08-04 2019-07-26 湖北美天生物科技股份有限公司 一种泰拉霉素a的合成方法
CN108003207B (zh) 2017-12-19 2019-05-10 海门慧聚药业有限公司 制备泰拉霉素的方法
CN111087433B (zh) * 2018-10-23 2023-03-21 湖北美天生物科技股份有限公司 一种泰拉霉素中间体的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
CA2064634C (en) 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
US5226958A (en) * 1991-04-11 1993-07-13 Pacemark, Inc. Sealant for pneumatic inner tubes and tubeless tires
EP0549040A1 (en) 1991-12-20 1993-06-30 Merck & Co. Inc. Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
HN1998000086A (es) 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
UA70972C2 (uk) 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків

Also Published As

Publication number Publication date
CN1259136A (zh) 2000-07-05
US6936592B2 (en) 2005-08-30
US6420536B1 (en) 2002-07-16
NO996106L (no) 2000-02-10
PL337505A1 (en) 2000-08-28
KR100396168B1 (ko) 2003-08-27
SK168399A3 (en) 2000-11-07
CN101691390A (zh) 2010-04-07
PL191601B1 (pl) 2006-06-30
US20040023896A1 (en) 2004-02-05
SK284171B6 (sk) 2004-10-05
BRPI9810519A (pt) 2000-09-19
BG64391B1 (bg) 2004-12-30
NZ500660A (en) 2002-03-01
CN1172947C (zh) 2004-10-27
DZ2514A1 (fr) 2003-02-01
CN1243766C (zh) 2006-03-01
PE79699A1 (es) 1999-08-25
DE69818665D1 (de) 2003-11-06
JP2000514098A (ja) 2000-10-24
UA67744C2 (uk) 2004-07-15
NZ514871A (en) 2003-08-29
FR04C0013I1 (sr) 2004-06-11
LU91076I9 (en) 2018-07-02
US6777393B2 (en) 2004-08-17
EP0988310A1 (en) 2000-03-29
HU228005B1 (en) 2012-08-28
CA2293823C (en) 2004-02-17
HRP980314A2 (en) 1999-04-30
NL300150I2 (nl) 2004-09-01
DE122004000018I1 (de) 2004-09-30
YU58699A (sr) 2002-08-12
RS49675B (sr) 2007-11-15
IL132809A0 (en) 2001-03-19
HUS1200028I1 (hu) 2016-08-29
EA199901015A1 (ru) 2000-06-26
LU91076I2 (fr) 2004-07-05
AU749816B2 (en) 2002-07-04
SI0988310T1 (en) 2004-02-29
ATE251173T1 (de) 2003-10-15
MY123354A (en) 2006-05-31
ID22992A (id) 1999-12-23
DE122004000018I2 (de) 2011-01-13
JP2002316933A (ja) 2002-10-31
PT988310E (pt) 2003-12-31
CO4950611A1 (es) 2000-09-01
HK1068893A1 (en) 2005-07-29
IS1998B (is) 2005-03-15
ME00876B (me) 2012-06-20
HRP980314B1 (en) 2004-04-30
EG24081A (en) 2008-05-11
HUP0002209A2 (hu) 2000-12-28
EA002441B1 (ru) 2002-04-25
HUP0002209A3 (en) 2003-05-28
NO316911B1 (no) 2004-06-21
BRPI9810519B8 (pt) 2022-11-16
JP3315704B2 (ja) 2002-08-19
CN1793155B (zh) 2010-05-12
ZA985017B (en) 1999-12-17
GT199800077A (es) 1999-12-02
HK1088014A1 (en) 2006-10-27
CN1566129A (zh) 2005-01-19
BRPI9810519B1 (pt) 2012-02-22
CZ298556B6 (cs) 2007-11-07
CA2293823A1 (en) 1998-12-17
AP9801255A0 (en) 1998-06-30
BG103945A (en) 2000-07-31
IS5252A (is) 1999-11-16
PA8452201A1 (es) 2000-05-24
US20040180842A1 (en) 2004-09-16
NL300150I1 (nl) 2004-08-02
AR013086A1 (es) 2000-12-13
EP0988310B9 (en) 2006-03-08
TW472060B (en) 2002-01-11
CZ442199A3 (cs) 2000-07-12
OA11224A (en) 2003-07-16
HK1028048A1 (en) 2001-02-02
AU7347598A (en) 1998-12-30
HN1998000086A (es) 1999-03-08
EP0988310B1 (en) 2003-10-01
AP1231A (en) 2003-12-11
NO996106D0 (no) 1999-12-10
FR04C0013I2 (sr) 2005-10-21
ES2205487T3 (es) 2004-05-01
KR20010013632A (ko) 2001-02-26
WO1998056802A1 (en) 1998-12-17
US20020061858A1 (en) 2002-05-23
TNSN98082A1 (fr) 2005-03-15
DE69818665T2 (de) 2004-04-29
MA24564A1 (fr) 1998-12-31
DK0988310T3 (da) 2003-12-15
CN1793155A (zh) 2006-06-28

Similar Documents

Publication Publication Date Title
UY25040A1 (es) Derivados de 9-desoxo-9a-aza-9a-homoeritromicina a c-4' sustituidos
UY25041A1 (es) Derivados de macrolidos c-4" sustituidos
UY25574A1 (es) Procedimiento para preparar nuevos macrolidos
UY25587A1 (es) Procedimientos para preparar derivados de eritromicina
CN105246334A (zh) 大环内酯及其制备和使用方法
CA2761756A1 (en) Treatment of urinary tract infections with antibacterial aminoglycoside compounds
BR9802851A (pt) Antibióticos de macrolìdeo substituìdos por c-4
KR20090117924A (ko) 거대고리 다형체, 이런 다형체 포함하는 조성물, 및 이의 사용 및 제조방법
AR024060A1 (es) Nuevos compuestos farmaceuticamente activos
ES2959665T3 (es) Compuestos de minociclina para biodefensa
EA200100396A1 (ru) Новые макролидные антибиотики
EA200100416A1 (ru) 13-членные азалиды и их применение в качестве антибиотических агентов
DK1132392T3 (da) Ketolid-antibiotika
CN108026133B (zh) 有效对抗多药耐药细菌的新的氨基糖苷抗生素
JP6411482B2 (ja) 窒素含有化合物およびその使用
WO2011140009A1 (en) Methods of using semi-synthetic glycopeptides as antibacterial agents
HRP20030907B1 (en) Pharmaceutical composition based on macrolides for topical application in ophthalmology
AU2011255630B2 (en) Treatment of Clostridium difficile infection in patients undergoing antibiotic therapy
BR112013021518A2 (pt) uso de derivados de poliaminoisoprenil em tratamento antibiótico ou antisséptico
AU2011255633B2 (en) Methods of treating recurring bacterial infection
US20200385416A1 (en) Novel inhibitors of the shikimate pathway
DE60104240D1 (de) Makrolid-Antibiotika
BR0012091A (pt) Sal de difosfato de um derivado de 4 substituìdo-9-desoxo-9a-aza-9a-homoeritromicina e sua composição farmacêutica
ES2245367T3 (es) Uso de tiamfenicol para el tratamiento de infecciones causadas por chlamydia pneumoniae.
ES2199278T3 (es) Derivados de espiro heterociclicos.

Legal Events

Date Code Title Description
VENC Patent expired

Effective date: 20180611